Correction: Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation.

Autor:	Lien VT; Department of Pharmacy, University of Oslo Oslo Norway v.t.lien@farmasi.uio.no., Kristiansen MK; Department of Pharmacy, University of Oslo Oslo Norway v.t.lien@farmasi.uio.no., Pettersen S; Department of Tumor Biology, Institute for Cancer Research, OUS Radiumhospitalet Oslo Norway., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, OUS Radiumhospitalet Oslo Norway., Krauss S; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo Oslo Norway.; Department of Immunology and Transfusion Medicine, Oslo University Hospital Oslo Norway., Olberg DE; Department of Pharmacy, University of Oslo Oslo Norway v.t.lien@farmasi.uio.no.; Norsk Medisinsk Syklotronsenter AS, OUS Rikshospitalet Oslo Norway., Waaler J; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo Oslo Norway.; Department of Immunology and Transfusion Medicine, Oslo University Hospital Oslo Norway., Klaveness J; Department of Pharmacy, University of Oslo Oslo Norway v.t.lien@farmasi.uio.no.
Jazyk:	angličtina
Zdroj:	RSC advances [RSC Adv] 2020 Jan 31; Vol. 10 (9), pp. 4927. Date of Electronic Publication: 2020 Jan 31 (Print Publication: 2020).
DOI:	10.1039/d0ra90007a
Abstrakt:	[This corrects the article DOI: 10.1039/C9RA08954C.]. (This journal is © The Royal Society of Chemistry.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu